Table 4.
Univariable | Multivariable | ||||||
---|---|---|---|---|---|---|---|
OR | 95% CI | p | OR | 95% CI | p | ||
AKI | Female | 0.77 | 0.56–1.04 | 0.088 | |||
Age | 1.03 | 1.02–1.04 | < 0.001 | 1.01 | 1.00–1.03 | 0.170 | |
HbA1c% | 1.05 | 0.93–1.18 | 0.433 | ||||
IMV | 8.17 | 5.67–11.77 | < 0.001 | 4.19 | 2.48–7.08 | < 0.001 | |
Vasopressor use | 9.04 | 6.19–13.22 | < 0.001 | 3.17 | 1.87–5.35 | < 0.001 | |
Cardiovascular | 1.95 | 1.47–2.58 | < 0.001 | 1.35 | 0.92–1.97 | 0.122 | |
Hypertension | 2.01 | 1.49–2.70 | < 0.001 | 1.46 | 1.01–2.12 | 0.044 | |
CKD | 2.67 | 1.92–3.71 | < 0.001 | 2.30 | 1.51–3.49 | < 0.001 | |
COPD | 1.33 | 0.89–1.99 | 0.164 | ||||
SAPS 3 | 1.05 | 1.03–1.06 | < 0.001 | 1.01 | 1.00–1.03 | 0.078 |
IMV invasive mechanical ventilation, COPD chronic obstructive pulmonary disease, CKD chronic kidney disease, KDIGO kidney disease improving global outcomes, SAPS simplified acute physiology score